Subscribe to RSS

DOI: 10.1055/s-0043-1769901
SARS-CoV-2 Genome Structure, Pathogenesis, Issues, and Challenges in Laboratory Diagnosis

Abstract
Severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 pandemic disease is an enveloped virus, showing genome similarity with bat coronavirus. This virus initially infects the upper respiratory tract, with subsequent spread to the lower respiratory tract. Despite the availability of antigen and antibody detection methods, reverse transcription-polymerase chain reaction (RT-PCR) is the diagnostic test of choice for this novel coronaviral infection. Care must be taken while interpreting the RT-PCR results, as single RT-PCR, especially in early days of infection, maybe false negative. The availability of cartridge-based nucleic acid amplification test has improved the diagnostic facilities in a peripheral setting of developing countries.
Publication History
Article published online:
24 July 2023
© 2023. National Academy of Medical Sciences (India). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res 2011; 81: 85-164
- 2 Chatterjee P, Nagi N, Agarwal A. et al. The 2019 novel coronavirus disease (COVID-19) pandemic: a review of the current evidence. Indian J Med Res 2020; 151 (2 & 3): 147-159
- 3 India COVID-Coronavirus Statistics- Wordometer. . Accessed May 4, 2023 at: https://www.worldometers.info/coronavirus/country/india/
- 4 Lu G, Wang Q, Gao GF. Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond. Trends Microbiol 2015; 23 (08) 468-478
- 5 Wu F, Zhao S, Yu B. et al. A new coronavirus associated with human respiratory disease in China. Nature 2020;579(7798):265–269 10.1038/s41586-020-2008-3 [published correc tion appears in Nature. 2020; 580(7803):E7]
- 6 de Haan CA, Rottier PJ. Molecular interactions in the assembly of coronaviruses. Adv Virus Res 2005; 64: 165-230
- 7 Lu R, Zhao X, Li J. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395 (10224): 565-574
- 8 van Boheemen S, de Graaf M, Lauber C. et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 2012; 3 (06) e00473-e12
- 9 Woo PC, Lau SK, Lam CS. et al. Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. J Virol 2012; 86 (07) 3995-4008
- 10 Yang D, Leibowitz JL. The structure and functions of coronavirus genomic 3′ and 5′ ends. Virus Res 2015; 206: 120-133
- 11 Lv L, Li G, Chen J, Liang X, Li Y. Comparative genomic analyses reveal a specific mutation pattern between human coronavirus SARS-CoV-2 and Bat-CoV RaTG13. Front Microbiol 2020; 11: 584717
- 12 Li C, He Q, Qian H, Liu J. Overview of the pathogenesis of COVID-19 (Review). Exp Ther Med 2021; 22 (03) 1011
- 13 Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol 2022; 20 (05) 270-284
- 14 Wang Y, Wang Z, Tse G. et al. Cardiac arrhythmias in patients with COVID-19. J Arrhythm 2020; 36 (05) 827-836
- 15 Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS. et al. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J 2022; 19 (01) 92
- 16 Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 2014; 6 (10) a016295
- 17 Apostolopoulos J, Davenport P, Tipping PG. Interleukin-8 production by macrophages from atheromatous plaques. Arterioscler Thromb Vasc Biol 1996; 16 (08) 1007-1012
- 18 Transmission of SARS-CoV-2: implications for infection prevention precautions. Accessed May 4, 2023 at: https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions
- 19 SARS-CoV-2 Variant Classifications and Definitions. Accessed May 4, 2023 at: https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications.html
- 20 Omicron has started replacing Delta variant in India, say sources. Accessed May 4, 2023 at: https://www.thehindu.com/news/national/omicron-has-started-replacing-delta-variant-in-india-say-sources/article38080589.ece
- 21 Del Rio C, Malani PN. COVID-19—new insights on a rapidly changing epidemic. JAMA 2020; 323 (14) 1339-1340
- 22 Fauci AS, Lane HC, Redfield RR. COVID-19—navigating the uncharted. N Engl J Med 2020; 382 (13) 1268-1269
- 23 Guan WJ, Ni ZY, Hu Y. et al; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382 (18) 1708-1720
- 24 Tang YW, Schmitz JE, Persing DH, Stratton CW. Laboratory diagnosis of COVID-19: current issues and challenges. J Clin Microbiol 2020; 58 (06) e00512-e00520
- 25 Emery SL, Erdman DD, Bowen MD. et al. Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus. Emerg Infect Dis 2004; 10 (02) 311-316 . 030759
- 26 Pan Y, Zhang D, Yang P, Poon LLM, Wang Q. Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis 2020; 20 (04) 411-412
- 27 Zou L, Ruan F, Huang M. et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020; 382 (12) 1177-1179
- 28 To KK, Tsang OT, Leung WS. et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 2020; 20 (05) 565-574
- 29 Wölfel R, Corman VM, Guggemos W. et al. Author Correction: Virological assessment of hospitalized patients with COVID-2019. Nature 2020; 588 (7839): E35 DOI: 10.1038/s41586-020-2196-x.
- 30 Kim C, Ahmed JA, Eidex RB. et al. Comparison of nasopharyngeal and oropharyngeal swabs for the diagnosis of eight respiratory viruses by real-time reverse transcription-PCR assays. PLoS One 2011; 6 (06) e21610 DOI: 10.1371/journal.pone.0021610.
- 31 Wang W, Xu Y, Gao R. et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA 2020; 323 (18) 1843-1844
- 32 Druce J, Garcia K, Tran T, Papadakis G, Birch C. Evaluation of swabs, transport media, and specimen transport conditions for optimal detection of viruses by PCR. J Clin Microbiol 2012; 50 (03) 1064-1065
- 33 Li Q, Guan X, Wu P. et al. Early transmission dynamics in Wuhan, China, of novel Coronavirus–infected pneumonia. N Engl J Med 2020; 382 (13) 1199-1207
- 34 Yu F, Yan L, Wang N. et al. Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients. Clin Infect Dis 2020; 71 (15) 793-798
- 35 Young BE, Ong SWX, Kalimuddin S. et al; Singapore 2019 Novel Coronavirus Outbreak Research Team. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 2020; 323 (15) 1488-1494
- 36 Zhang W, Du RH, Li B. et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 2020; 9 (01) 386-389
- 37 Chu DKW, Pan Y, Cheng SMS. et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem 2020; 66 (04) 549-555
- 38 Blow JA, Dohm DJ, Negley DL, Mores CN. Virus inactivation by nucleic acid extraction reagents. J Virol Methods 2004; 119 (02) 195-198
- 39 Kumar M, Mazur S, Ork BL. et al. Inactivation and safety testing of Middle East respiratory syndrome coronavirus. J Virol Methods 2015; 223: 13-18
- 40 Ai JW, Zhang Y, Zhang HC, Xu T, Zhang WH. Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned. Emerg Microbes Infect 2020; 9 (01) 597-600
- 41 Loeffelholz MJ, Tang YW. Laboratory diagnosis of emerging human coronavirus infections - the state of the art. Emerg Microbes Infect 2020; 9 (01) 747-756
- 42 CDRI develops cost-effective, indigenous Omicron testing kit. Accessed May 4, 2023 at: https://timesofindia.indiatimes.com/city/lucknow/cdri-develops-cost-effective-indigenous-omicron-testing-kit/articleshow/89078818.cms
- 43 China National Health Commission. . 2020. New coronavirus pneumonia prevention and control protocol, 7th ed. National Commission of the People's Republic of China. (In Chinese.) Accessed May 4, 2023 at: http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf
- 44 Holshue ML, DeBolt C, Lindquist S. et al; Washington State 2019-nCoV Case Investigation Team. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020; 382 (10) 929-936
- 45 Kam KQ, Yung CF, Cui L. et al. A well infant with coronavirus disease 2019 with high viral load. Clin Infect Dis 2020; 71 (15) 847-849
- 46 Liu Y, Yan LM, Wan L. et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis 2020; 20 (06) 656-657
- 47 Cheng VCC, Wong SC, Chen JHK. et al. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infect Control Hosp Epidemiol 2020; 41 (05) 493-498
- 48 Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology 2003; 8 (Suppl 1, Suppl): S9-S14
- 49 Liu Y, Eggo RM, Kucharski AJ. Secondary attack rate and superspreading events for SARS-CoV-2. Lancet 2020; 395 (10227): e47 DOI: 10.1016/S0140-6736(20)30462-1.
- 50 Advisory for COVID-19 Home Testing using Rapid Antigen Tests (RATs). Accessed May 4, 2023 at: https://www.icmr.gov.in/pdf/COVID/kits/COVID_Home_Test_Kit_13012022.pdf
- 51 Yadav AK, Ghosh S, Kotwal A. et al. Seroconversion among COVID-19 patients admitted in a dedicated COVID hospital: a longitudinal prospective study of 1000 patients. Med J Armed Forces India 2021; 77 (Suppl. 02) S379-S384
- 52 Guidelines for Handling, Treatment and Disposal of Waste Generated during Treatment/Diagnosis/ Quarantine of COVID-19 Patients. Accessed May 4, 2023 at: https://cpcb.nic.in/uploads/Projects/Bio-Medical-Waste/BMW-GUIDELINES-COVID_1.pdf